Laura Fregonese (London, United Kingdom), Nicolas Kahn (Heidelberg, Germany)
Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD
Evgenia A. Kochetkova (Strasbourg, France), Ludmila G. Ugay, Evgenia A. Kochetkova, Vera A. Nevzorova, Yuliya V. Maistrovskaia
|  |
Identification of clinical phenotypes in patients with and without COPD using cluster analysis
Miguel Divo (Boston, United States of America), Miguel Divo, Ciro Casanova, Jose M. Marin, Bartolome Celli, Juan Pablo de Torres, Francesca Polverino, Rebeca Baz, Elizabeth Cordoba-Lanus, Victor Pinto-Plata
|  |
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Maeva Zysman (Vincennes, France), Maeva Zysman, Pierre Regis Burgel, Jean Louis Paillasseur, Pascal Chanez, Denis Caillaud, Roger Escamilla, Isabelle Court Fortune, Pascal Nesme Meyer, Graziella Brinchault Rabin, Gaetan Deslee, Thierry Perez, Christophe Pinet, Nicolas Roche
| |
Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Carolina Mesquita (Botucatu, Brazil), Carolina Mesquita, Robson Prudente, Laura Caram, Caroline Knaut, Estefânia Franco, Duelene Ludimila Nogueira, Liana Coelho, Irma Godoy, Suzana Minamoto
| |
Hypogonadism as a factor influencing health condition in COPD patients
Renata Rubinsztajn (Warszawa, Poland), Renata Rubinsztajn, Tadeusz Przybylowski, Marta Maskey-Warzechowska, Krzysztof Kartwat, Ryszarda Chazan
| |
Endothelial dysfunction in patients with chronic obstructive pulmonary disease and concomitant arterial hypertension and its correction by telmisartan plus amlodipine fixed combination
Laura Bolieva (Vladikavkaz, Russian Federation), Laura Bolieva
| |
Prevalence and clinical correlates of patient-reported autonomic symptoms among subjects with COPD
Jibril Mohammed (Ghent, Belgium), Jibril Mohammed, Eric Derom, Jessica Van Oosterwijck, Hellen Da Silva, Patrick Calders
| |
Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
Wafaa Gadallah (Assiut, Egypt), Wafaa Gadallah, Atef Farouk, Abd Elazeem Aboelfadl, Manal Alkhawaga
| |
The functional state of the diaphragm in COPD patients with hypoxemia
Darya Sklyarova (Saint-Petersburg, Russian Federation), Vladimir Volchkov, Olga Titova, Darya Sklyarova, Natalia Kusubova
| |
Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD
Marek Plutinsky (Brno, Czech Republic), Marek Plutinsky, Barbora Novotna, Patrice Popelkova, Zatloukal Jaromir, Vladimir Koblizek, Karek Hejduk, Michal Svoboda
| |
Eosinophilic versus non-eosinophilic COPD cannot be distinguished by lung function nor CT determined emphysema or airway remodelling
Leena George (Leicester, United Kingdom), Leena George, Chris Newby, Sumit Gupta, Deepak R. Subramanian, David G. Parr, Timm Greulich, Dave Singh, Loems Ziegler-Heitbrock, Chris Brightling
| |
Blood eosinophils and outcomes in COPD
Jose M. Marin Trigo (Zaragoza, Spain), Jose M. Marin Trigo, Maria Martinez, Pablo Cubero, Marta Forner, Marina Saetta, Manuel G. Cosio
| |
Concordance among GOLD, NICE and LLN criteria in the spirometry diagnosis of airflow obstruction
Javier Juan Garcia (León, Spain), Javier Juan Garcia, Silvia García García, Luis Carazo Fernández, Jose Cesáreo Naveiro Rilo, Francisco Martínez García, Jose Luis Palomo García, Elena Bollo De Miguel, Florentino Díez Fernández
| |
Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD
Etsuko Tagaya (Tokyo, Japan), Etsuko Tagaya, Sayo Fujimoto, Ayako Kubo, Akitoshi Sato, Osamitsu Yagi, Kiyoshi Takeyama, Mitsuko Kondo, Jun Tamaoki
| |
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Anna Dudnikova (Krasnodar, Russian Federation), Anna Dudnikova, Elena Bolotova
| |
LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
David Lomas (London, United Kingdom), David Lomas, David Lipson, Helen Barnacle, Ruby Birk, Noushin Brealey, Chang-Qing Zhu, Maggie Tabberer
| |